Sahajanand Medical Technologies prepares for market debut with Rs 2,000 crore IPO, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Morgan Stanley PE Asia and Samara Capital collectively hold a 49% stake, while Kotak Pre-IPO Opportunities Fund holds 6%, and the Kotadia family owns the remaining 45%. Morgan Stanley is expected to fully exit the investment as part of its lifecycle, with Samara Capital and Kotak Fund likely making partial exits, sources added., Morgan Stanley PE Asia and Samara Capital collectively hold a 49% stake, while Kotak Pre-IPO Opportunities Fund holds 6%, and the Kotadia family owns the remaining 45%. Morgan Stanley is expected to fully exit the investment as part of its lifecycle, with Samara Capital and Kotak Fund likely making partial exits, sources added., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *